{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:52:53Z","timestamp":1759341173688},"reference-count":16,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.optm.2010.11.016","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T08:00:59Z","timestamp":1321948859000},"page":"739-743","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis C and interferon-associated retinopathy: A case report"],"prefix":"10.1016","volume":"82","author":[{"given":"Ann M.","family":"Van Wie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.optm.2010.11.016_bib1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.3748\/wjg.v11.i19.2949","article-title":"Expression of bcl-2 Protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy","volume":"11","author":"Anatol","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.optm.2010.11.016_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00055735-200212000-00014","article-title":"ocular manifestations of hepatitis C virus infection","volume":"13","author":"Zegans","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.optm.2010.11.016_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjo.82.3.323","article-title":"Interferon associated retinopathy","volume":"82","author":"Hayasaka","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2010.11.016_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2036.2005.02365.x","article-title":"Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation","volume":"21","author":"Chisholm","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.optm.2010.11.016_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0161-6420(02)01741-4","article-title":"posterior segment complications in patients with hepatitis c treated with interferon and ribavirin","volume":"110","author":"Schulman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2010.11.016_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.18388\/abp.2005_3487","article-title":"Existing and future therapeutic options for hepatitis C virus infection","volume":"52","author":"Bretner","year":"2005","journal-title":"Acta Biochimica Polonica"},{"key":"10.1016\/j.optm.2010.11.016_bib7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1099\/0022-1317-81-7-1631","article-title":"Replication of hepatitis C virus","volume":"81","author":"Bartenschlager","year":"2000","journal-title":"J General Virol"},{"key":"10.1016\/j.optm.2010.11.016_bib8","first-page":"29","article-title":"Treatment of chronic hepatitis C","volume":"50","author":"Marcellin","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.optm.2010.11.016_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.mcg.0000135897.30038.16","article-title":"Visual side effects of pegylated interferon during therapy for chronic hepatitis C","volume":"38","author":"Willson","year":"2004","journal-title":"Infect J Clin Gastroenterol"},{"key":"10.1016\/j.optm.2010.11.016_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0002-9394(01)00836-4","article-title":"Retinopathy associated with high-dose interferon alfa-2b therapy","volume":"131","author":"Hejny","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2010.11.016_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.eye.6700604","article-title":"Hepatitis C virus-associated keratitis","volume":"18","author":"Jain","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.optm.2010.11.016_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0676.2001.021003192.x","article-title":"Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C","volume":"21","author":"Saito","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.optm.2010.11.016_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon-associated retinopathy","volume":"111","author":"Guyer","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2010.11.016_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s005350170072","article-title":"Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?","volume":"36","author":"Nishiguchi","year":"2001","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.optm.2010.11.016_bib15","first-page":"409","article-title":"Purtscher\u2019s retinopathy","author":"Buckley","year":"1995","journal-title":"Eponyms in Medicine Revisited"},{"key":"10.1016\/j.optm.2010.11.016_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3928\/1542-8877-20010501-19","article-title":"Purtscher\u2019s retinopathy in a patient with acute pancreatitis","volume":"32","author":"Umlas","year":"2001","journal-title":"Ophthalmic Surg Lasers"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183911005033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183911005033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T15:45:52Z","timestamp":1639755952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183911005033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1529183911005033"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2010.11.016","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}